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Abstract
Macrophages are a heterogeneous cell population strongly influenced by differentiation sti-
muli that become susceptible to HIV-1 infection after inactivation of the restriction factor
SAMHD1 by cyclin-dependent kinases (CDK). Here, we have used primary human mono-
cyte-derived macrophages differentiated through different stimuli to evaluate macrophage
heterogeneity on cell activation and proliferation and susceptibility to HIV-1 infection. Stimu-
lation of monocytes with GM-CSF induces a non-proliferating macrophage population
highly restrictive to HIV-1 infection, characterized by the upregulation of the G1/S-specific
cyclin D2, known to control early steps of cell cycle progression. Knockdown of cyclin D2,
enhances HIV-1 replication in GM-CSF macrophages through inactivation of SAMHD1
restriction factor by phosphorylation. Co-immunoprecipitation experiments show that cyclin
D2 forms a complex with CDK4 and p21, a factor known to restrict HIV-1 replication by
affecting the function of the downstream cascade that leads to SAMHD1 deactivation.
Thus, we demonstrate that cyclin D2 acts as regulator of cell cycle proteins affecting
SAMHD1-mediated HIV-1 restriction in non-proliferating macrophages.
Author Summary
Macrophages are a heterogeneous population of immune cells that provide crucial innate
immune defense against pathogens, including HIV-1. The molecular biology of HIV-1
infection in macrophages is influenced by the presence of the host cell restriction factor
SAMHD1, which is regulated by phosphorylation by cyclin dependent kinases, the cata-
lytic proteins responsible for cell cycle progression. This study shows that differentiation
stimuli strongly influence macrophage cell cycle and proliferation characteristics as well as
susceptibility to HIV-1 infection through modulation of SAMHD1 activation. We have
identified cyclin D2 as the key step controlling susceptibility to HIV-1 infection by
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modulation of the signaling pathway leading to SAMHD1 phosphorylation. We show that
a complex formed by cyclin D2-CDK4-p21 in GM-CSF macrophages is responsible for
the lack of the active CDK, which phosphorylates SAMHD1. This situation is reversed in
the absence of cyclin D2, leading to the activation of CDKs and subsequent phosphoryla-
tion of its substrates, including SAMHD1. Thus, we propose that the differential expres-
sion of the G1/S-specific cyclin D2 controls the HIV-1 restriction pathway in primary
macrophages.
Introduction
Macrophages are a highly heterogeneous cell population that plays a prominent role in innate
immune system as key effector cells for the elimination of pathogens, infected cells and cancer
cells [1, 2]. Macrophages also play an essential role in maintaining tissue homeostasis by sup-
porting tissue development and repairing damaged tissue architecture [1, 3]. Macrophage dif-
ferentiation from monocytes occurs in the tissue in concomitance with the acquisition of a
functional phenotype that depends on microenvironmental signals, accounting for the wide
and apparently opposed variety of macrophage functions [4, 5].
Macrophages, as well as other myeloid lineage cells, become susceptible to HIV-1 infection
after degradation or inactivation of the restriction factor SAMHD1, a triphosphohydrolase
enzyme that controls the intracellular level of dNTPs [6–9]. Phosphorylation of SAMHD1 by
cyclin dependent kinases (CDK) has been strongly associated with inactivation of the virus
restriction mechanism, providing an association between virus replication and cell prolifera-
tion [10–12]. The activity of CDK is regulated by the binding of cyclins, a family of proteins
characterized by a periodic, cell-cycle dependent pattern of expression [13, 14]. Cyclin-CDK
complexes govern cell cycle progression and proliferation of mammalian cells and thus, pin-
point the specific time in which an event occurs during the cell cycle [13, 14]. We and others
have shown that the complex cyclin D3-CDK6 acting upstream of CDK2 controls SAMHD1
phosphorylation and function in primary lymphocytes and macrophages [11, 15–17]. Cyclin-
CDK function is also controlled by cyclin dependent kinase inhibitors (CDKIs) that generally
act as negative regulators of the cell cycle by binding to CDKs and inhibiting their kinase activ-
ity [18]. Of particular importance is p21/waf1, a G1/S phase CDKI, that may also control HIV-
1 replication through SAMHD1 [19, 20].
D-type cyclins (cyclins D1, D2 and D3) are regarded as essential links between cell environ-
ment and the core cell cycle machinery. D-type cyclins drive cells through the G1 restriction
point and into the S phase, after which growth factor stimulation is no longer essential to com-
plete cell division [21]. D-type cyclins share the capacity to activate both CDK4 and CDK6
[14]. Studies on single, double and triple cyclin D knockout mice revealed that D-type cyclin
complexes have redundant functions. However, different D-type cyclins exhibit distinct expres-
sion patterns depending on the cell type, indicating that each D-type cyclin has essential func-
tions in particular settings, as suggested by the narrow and tissue-specific phenotypes of the
knockout mice (reviewed in [21]).
Here, we have used primary human monocyte-derived macrophages (MDMs) differentiated
through different stimuli to evaluate macrophage heterogeneity on cell activation and prolifer-
ation, characteristics that influence gene and protein expression patterns and determine sus-
ceptibility to HIV-1 infection. The comparative study has led to the identification and
characterization of a cell cycle dependent pathway that restricts HIV-1 infection in primary
macrophages. These non-proliferating macrophage population is characterized by a high
expression of the G1/S-specific cyclin D2. Cyclin D2 acts through the binding to CDK4 and
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p21 in GM-CSF macrophages, a complex which is responsible for the lack of the active CDK
that phosphorylates SAMHD1. Data from mouse peritoneal macrophages confirmed the exis-
tence of cyclin D2 expressing macrophages in vivo, further supporting the key role of cyclin
D2.
Results
Differentiation stimuli determine cell cycle progression and susceptibility
to HIV-1 infection due to SAMHD1 activation in primary macrophages
Primary monocyte-derived macrophages were differentiated either with M-CSF or GM-CSF,
with the aim to characterize differences in cell activation and proliferation patterns and suscep-
tibility to HIV-1 infection. Differentiated macrophages displayed different morphological char-
acteristics dependent on the differentiation stimuli, but no significant differences in cell surface
antigen expression or HIV receptor and co-receptors were observed (S1A Fig). Interestingly,
cell proliferation and cell cycle patterns were significantly different between macrophage types,
i.e., M-CSF macrophages proliferated at higher rates than GM-CSF measured by intracellular
Ki67 staining (Fig 1A, 7% vs. 0.5% of Ki67+ cells in M-CSF and GM-CSF macrophages respec-
tively, p = 0.02). Similar results were obtained analyzing cell cycle profile by DNA and RNA
content staining (Fig 1B), showing higher percentage of cells in S/G2M stage in M-CSF than
GM-CSF macrophages.
Susceptibility to HIV-1 infection was also significantly different, being M-CSF macrophages
in average roughly 10-fold more susceptible to HIV-1 infection (Fig 1C, left panels and 1D,
p = 0.0072), which correlated with higher dNTP levels in cycling M-CSF macrophages com-
pared to GM-CSF as previously reported (S1B Fig and [22, 23]). These results point towards
the established link between cell cycle progression and susceptibility to infection as the deter-
minant of the differences observed between macrophage types, a process where SAMHD1
restriction is central [11]. Indeed, degradation of SAMHD1 by HIV-2 Vpx increased HIV repli-
cation in both macrophage types, minimizing the initial differences in infection (Fig 1C, right
panels, and 1D, p = 0.12). No differences were found in antiviral activity of drugs either target-
ing viral reverse transcription (AZT or nevirapine) or the cell cycle inhibitor palbociblib [24]
(PD, specifically targeting CDK4/6 and inhibiting SAMHD1 phosphorylation) between M-CSF
and GM-CSF differentiated macrophages (Fig 1E and 1F). Moreover, after SAMHD1 degrada-
tion by HIV-2 Vpx, decreased antiviral potency of AZT and a complete loss of PD antiviral
activity were observed, suggesting that cellular events leading to SAMHD1-mediated viral
restriction were similar in both types of macrophages [11, 15]. Similar results were obtained
when culturing macrophages in the presence of human serum, indicating that the differentia-
tion stimuli induced by the cytokine determines the macrophage phenotype (S2 Fig).
GM-CSF macrophages show a significant increase in D-type cyclins
expression
To further investigate the molecular determinants of the observed differences between macro-
phages types, expression of cell cycle genes implicated in SAMHD1 control were evaluated (Fig
2A). No major gene expression differences were observed, except for a significant upregulation
of D-type cyclins (CCND1, 2-fold, p = 0.0006; CCND2, 40-fold, p = 0.0004; and CCND3, 3-fold
p = 0.0002) and the CDK inhibitor p21 (CDKN1A, 4-fold, p = 0.038) in GM-CSF macrophages
(Fig 2A). Analysis of protein expression confirmed the upregulation of cyclin D2, cyclin D3
and p21 in GM-CSF macrophages, and revealed a clear downregulation of CDK protein levels
(CDK1, CDK2 and CDK6 but not of CDK4) and the negative cell cycle regulator p27 (Fig 2B).
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As expected, no differences were found in SAMHD1 expression but a change in SAMHD1 acti-
vation was observed, being only phosphorylated and partially inactivated inM-CSFmacrophages
(Fig 2B, upper panels). Importantly, mouse peritoneal macrophages showed a similar expression
pattern than that observed in GM-CSF macrophages, suggesting the existence of cyclin D2
expressing macrophages in vivo (S3 Fig). From a functional point of view, stimulation with LPS
resulted in the upregulation of IFNB1, IL-10 and CCL-2 production in both types of macro-
phages, albeit basal expression levels were different inM-CSF and GM-CSF as reported elsewhere
[25, 26] (Fig 2C). These results demonstrate that differentiation stimuli strongly impact the cell
cycle profile of primary macrophages, and consequently their capacity to support HIV-1 replica-
tion, that may be in part determined by differences in the restriction factor SAMHD1 activation.
Differential expression of D-type cyclins, and specially cyclin D2 may represent key regulatory
proteins that shape the distinct cell cycle profile and affect HIV-1 restriction.
D-type cyclins have differential effects on HIV-1 replication depending
on the macrophage type
The role of D-type cyclins in macrophage differentiation and HIV-1 susceptibility was further
evaluated by RNA interference. Effective and specific downregulation of cyclin D2 and cyclin D3
was achieved at both mRNA and protein level in M-CSF and GM-CSF macrophages (Fig 3A and
3B). Higher expression of CCND2 in the GM-CSF macrophage population compared to M-CSF,
was again clearly observed in all conditions tested (Fig 3A, left panel, and 3B). SAMHD1 expres-
sion was not affected by D-type cyclin inhibition, as measured by mRNA level (S4A Fig) or pro-
tein expression (Fig 3B). However, different effects on SAMHD1 phosphorylation were observed
depending on the targeted cyclin and the differentiation stimuli. As previously reported [16],
cyclin D3 knockdown resulted in the abolishment of SAMHD1 phosphorylation in M-CSF mac-
rophages compared to a non-targeting siRNA (Fig 3B, lanes 1–3), an effect that could not be eval-
uated in GM-CSF macrophages due to low expression levels of phosphorylated SAMHD1. On
the contrary, cyclin D2 knockdown resulted in increased SAMHD1 phosphorylation in the
GM-CSF macrophage population (Fig 3B, lanes 4–6). Similarly, cyclin D3 but not cyclin D2
knockdown was associated with lower cell proliferation measured as percentage of Ki67 positive
macrophages, an effect that was evident in proliferating M-CSF macrophages, but difficult to
evaluate in non-proliferating GM-CSF macrophages (Fig 3C).
siRNA-treated macrophages were tested for their capacity to support HIV-1 replication.
HIV-1 replication was inhibited after cyclin D3 knockdown in M-CSF macrophages (roughly
60% inhibition, p = 0.0095), whereas inhibition of cyclin D2 expression did not have any effect
(Fig 3D, white bars). Conversely, in GM-CSF macrophages cyclin D2 downregulation led to a
significant increase of HIV-1 replication (3-fold increase, p = 0.03), but no effect was observed
in cyclin D3 knockdown macrophages (Fig 3D, black bars). These results demonstrated differ-
ent roles for cyclin D2 and D3 at controlling cell proliferation and HIV-1 infection.
Fig 1. Susceptibility to HIV-1 infection in primary macrophages depends on differentiation stimuli. (A) Evaluation of cell proliferation by Ki67
staining. Histograms of a representative donor showing Ki67 staining in M-CSF and GM-CSF derived macrophages. Percentage of positive cells is
shown in each case. (B) Dot plots representing cell cycle profile showing DNA (7-AAD) and RNA (Pyronin Y) content of M-CSF and GM-CSF
differentiated macrophages quantified by flow cytometry. Data from a representative donor is shown. (C) Dot plots of infected M-CSFmacrophages
(upper panels) or GM-CSFmacrophages (lower panels) untreated (left) or after treatment (right) with VLPVpx. Data from a representative donor is shown.
(D) Percentage replication in M-CSFMDM and GM-CSFMDM untreated (white bars) or transduced with VLPVpx (black bars). Mean ± SD of 4 different
donors performed in triplicate is shown. (E) and (F) Drug sensitivity in M-CSF and GM-CSF differentiated macrophages. Antiviral activity of zidovudine
(AZT, 1 μM), nevirapine (NVP, 5 μM) and palbociclib (PD, 4 μM) was evaluated in M-CSF (E) and GM-CSF (F) MDM, untreated (white bars) or
transduced with VLPVpx (black bars). Antiviral potency was decreased with AZT and completely lost with PD after degradation of SAMHD1 with VLPVpx.
Mean ± SD of at least 3 different donors performed in triplicate is shown. ND; no-drug, ns; not significant, * p<0.05; ** p<0.005.
doi:10.1371/journal.ppat.1005829.g001
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Cyclin D2 expression restricts HIV-1 replication by controlling SAMHD1
activation in GM-CSF macrophages
To determine the molecular bases of cyclin D2 effect on HIV-1 replication in GM-CSF macro-
phages, most common protein interactions for cyclin D2 were identified by database searches
[27, 28]. p21, CDK4 and CDK6 were found as the most common proteins bound to cyclin D2.
Cyclin D2 is known to form a complex with CDK4 and CDK6 where it functions as a regula-
tory subunit of both CDK at G1/S transition [18]. However, CDK6 expression could not be
detected in GM-CSF macrophages (Fig 2B), therefore, further characterization was centered in
D-type cyclins and their interactors p21 and CDK4.
RNA interference was used to effectively and specifically downregulate cyclin D2, cyclin D3,
p21 and CDK4 expression in GM-CSF macrophages (Fig 4A and S4B Fig). Evaluation of gene
expression in siRNA-treated macrophages suggested that CCND2 (cyclin D2) and CDKN1A
(p21) expression is cross-regulated, as interference of CCND2 expression lead to a significant
downregulation of CDKN1A (Fig 4A, third panel, 40% inhibition compared to mock macro-
phages, p = 0.007) and a similar trend was observed when CCND2 expression was evaluated in
siCDKN1Amacrophages, although it did not reach statistically significance (Fig 4A, first panel,
30% inhibition compared to mock, p = 0.06). Protein expression confirmed the effective downre-
gulation of all target proteins (Fig 4B) as well as the mutual regulation of cyclin D2 and p21, as
knockdown of cyclin D2 or p21 induced a downregulation of p21 or cyclin D2 expression, respec-
tively (Fig 4B, lane 3 and lane 5). As above, SAMHD1 expression was not altered in siRNA-
treated macrophages, but significant changes were observed in its phosphorylated form, showing
an increased phophorylation in cyclin D2 and p21 knockdownmacrophages (Fig 4B, two upper
panels). Cell proliferation status showed a small percentage of proliferating cells in all cases, albeit
a slight increase in Ki67 positive cells was observed in cyclin D2 and p21 knockdown GM-CSF
macrophages (Fig 4C, upper panels). Cell cycle analysis did not show any significant differences
between the different macrophages (Fig 4C, lower panels). Altogether, these results reinforce the
idea of cyclin D2 and p21 sharing a common regulatory pathway in GM-CSF macrophages.
siRNA-treated GM-CSF macrophages were also tested for their capacity to support HIV-1
replication. Knockdown of cyclin D2 and p21 significantly increased HIV-1 replication in
GM-CSF macrophages infected with a VSV-pseudotyped NL4-3 GFP expressing virus (roughly
4-fold increase, p = 0.0007 for siCCND2 and p = 0.0003 for siCDKN1A, respectively, Fig 4D).
On the contrary, no effect was seen when cyclin D3 or CDK4 expression were inhibited. Provi-
ral DNA formation was also enhanced in cyclin D2 and p21 knockdown GM-CSF macro-
phages in short-term infections with the fully replicative HIV-1 R5-tropic strain BaL (roughly
3-fold increase, p = 0.007 for siCCND2 and p = 0.03 for siCDKN1A respectively, Fig 4E). As
expected, the HIV-1 reverse transcriptase inhibitor AZT completely blocked proviral DNA for-
mation, while the HIV-1 integrase inhibitor Raltegravir (RAL) did not have an effect on viral
DNA formation (Fig 4E). Importantly, confirmatory siRNA sequences targeting Cyclin D2
showed similar effects on infection and proviral DNA formation after HIV-1 BaL infection
(S4C and S4D Fig), indicating that cyclin D2 acts as part of a viral restriction mechanism in
Fig 2. M-CSF and GM-CSFmacrophages present differential expression of cell cycle-related proteins and SAMHD1 activation. (A)Gene
expression of cell cycle-related genes and SAMHD1 restriction pathway. mRNA levels of SAMHD1, CDK1, CDK2, CDK4 andCDK6, the
corresponding cyclins (A2, B1, B2, D1, D2, D3, E1 and E2) and CDK2 inhibitor p21 (CDKN1A) was quantified in M-CSF (white bars) and
GM-CSF (black bars) differentiated macrophages. Data is normalized to M-CSF relative expression. Mean ± SD of 3 independent donors is
shown. ** p<0.005; *** p<0.0005. (B)Western blot showing protein expression of different cell cycle proteins, SAMHD1 expression and
activation and Hsp90 as loading control. Two representative donors are shown. M; M-CSFMDM, GM; GM-CSFMDM. (C) Induction of gene
expression following LPS (100 ng/ml) treatment of M-CSF and GM-CSFmacrophages. Expression of IFNB1, CCL-2 and IL-10were evaluated.
Data is normalized to untreated M-CSF condition. Mean ± SD of 3 independent donors is shown.
doi:10.1371/journal.ppat.1005829.g002
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GM-CSF macrophages. No significant differences in basal cytokine expression and the capacity
to induce cytokine expression after LPS stimulation was also preserved in cyclin D2 or p21
knockdown macrophages, suggesting no major functional abnormalities as a result of inhibi-
tion of cyclin D2 or p21 (S5 Fig).
Cyclin D2 associates with p21 and CDK4 in GM-CSF macrophages
To investigate the interaction between cyclin D2 and p21, a plasmid expressing a fusion protein
Flag-p21 [29] was transfected into HEK293T cells and p21 was immunoprecipitated using Flag-
specific agarose beads (Fig 5A). Cyclin D2 co-immunoprecipitated with Flag-p21 (Fig 5A, last
lane) and it was not identified when using lysates frommock-transfected cells (M), demonstrating
the existence of a protein complex with cyclin D2 and p21. The presence of a CDK in the complex
was also investigated and found that CDK1, but not CDK4 or CDK6, immunoprecipitated
together with cyclin D2 and p21 in HEK293T cells. The interaction of cyclin D2 and p21 was con-
firmed by overexpression of a cyclin D2–HA fusion protein [30] in HEK293T cells followed by
immunoprecipitation using HA-specific agarose beads. As expected, p21 co-immunoprecipitated
with cyclin D2-HA and CDK1 but not CDK4 (Fig 5B), demonstrating the existence of a protein
complex between cyclin D2, p21 and a relevant CDK associated to SAMHD1 function.
Deregulation of the cell cycle is a hallmark of most laboratory adapted cell lines in which
CDK1 may play a preponderant role in controlling cell proliferation, while other CDKs may
have a tissue specific role in driving the cell cycle and cell differentiation [13]. Taking this into
account, co-immunoprecipitation experiments of endogenous cyclin D2 and p21 in GM-CSF
macrophages were also performed. Importantly, immunoprecipitation of endogenous cyclin
D2 or p21 resulted in the identification of p21 or cyclin D2, respectively, demonstrating the
coexistence of both proteins in a complex also in GM-CSF primary macrophages (Fig 5C and
5D). The presence of a CDK in the same protein complex was also investigated and CDK4, but
not CDK1, was found to co-immunoprecipitate with either cyclin D2 or p21 in primary macro-
phages (Fig 5C and 5D). When immunoprecipitating p21 higher amounts of cyclin D2 and
CDK4 were found than when immunoprecipitating cyclin D2, which might indicate that most
p21 is found complexed with cyclin D2 and CDK4, whereas in the case of cyclin D2, only a
fraction of the total protein is bound to p21 and CDK4 (Fig 5D). These results further demon-
strate the existence of a protein complex formed by cyclin D2, p21 and CDK4 that may govern
cell cycle progression and HIV-1 susceptibility in GM-CSF primary macrophages.
Cyclin D2 expression controls CDK1 and CDK2 activity in GM-CSF
macrophages
CDK1 and CDK2 have been identified as the kinases responsible for SAMHD1 phosphoryla-
tion in cycling cells and macrophages, respectively [10–12]. Thus, to delineate the molecular
Fig 3. RNAi of cyclin D2 and cyclin D3 differently impact viral replication depending on MDM type. (A) Effective and specific knockdown
ofCCND2 andCCND3 expression by siRNA. Relative mRNA expression of CCND2 (left panel) andCCND3 (right panel) in M-CSF (white bars)
and GM-CSF (black bars) macrophages. mRNA of the corresponding cyclin was measured by quantitative PCR and normalized to GAPDH
expression. Data represents mean ± SD of 3 different donors and is normalized to Mock-transfected M-CSFmacrophages. (B) Protein
expression and SAMHD1 activation in cyclin D2 and cyclin D3 knockdownmacrophages. Western blot showing cyclin protein expression,
SAMHD1 expression and activation in siRNA-treated M-CSF and GM-CSFmacrophages. SAMHD1 inactivation is reduced in siCCND3 (D3)
M-CSFmacrophages and increased in siCCND2 (D2) GM-CSFmacrophages compared to the corresponding non-targeting siRNA (NT).
Hsp90 was used as loading control. A representative donor is shown. (C) Evaluation of cell proliferation in cyclin D2 and cyclin D3 knockdown
macrophages. Ki67 staining of siRNA-treated M-CSF (upper panels) and GM-CSF (lower panels) derived macrophages. Histograms from a
representative donor are shown. (D) HIV-1 replication in siRNA-treated M-CSF or GM-CSFmacrophages. Transfected MDMwere infected with
a VSV-pseudotyped, GFP-expressing HIV-1 and infection measured 72h later by flow cytometry. Data represent percentage replication relative
to mock-transfected cells in M-CSF (white bars) or GM-CSF (black bars) macrophages. Mean ± SD of 3 different donors performed in triplicate
is shown. * p<0.05; ** p<0.005; *** p<0.0005.
doi:10.1371/journal.ppat.1005829.g003
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pathway regulated by cyclin D2, expression and activation of CDK1 and CDK2 were analyzed
in siRNA-treated GM-CSF macrophages (Fig 6). Knockdown of cyclin D2 enhanced signifi-
cantly CDK1 mRNA (roughly 3-fold, p = 0.0021, Fig 6A, left panel) and protein expression
(Fig 6B). Although no significant upregulation of CDK2 expression was observed (Fig 6A,
right panel), CDK2 CDK2 regulatory phosphorylation at Thr130 (pCDK2, Fig 6B) was signifi-
cantly increased suggesting a higher activity of CDK2.
According to the classical model of cell cycle control, CDK4 or CDK6 regulate events in
early G0 to G1 phase, CDK2 triggers S phase, CDK2/CDK1 regulate the completion of the S
phase and CDK1 is responsible for mitosis [13]. Thus, the complex formed by cyclin
D2-CDK4-p21 might be responsible for the lack of active CDK2 and CDK1 expression in
GM-CSF macrophages. This situation is reversed in the absence of cyclin D2, leading to the
activation of CDK2 and CDK1 with the subsequent phosphorylation of its substrates, including
SAMHD1. As a consequence, SAMHD1 phosphorylation results in inactivation of virus
restriction and enhancement of HIV-1 replication (Fig 6C).
Discussion
Macrophages are key components of the innate immune system that reside in tissues, where
they function as immune sentinels. Although macrophage heterogeneity has classically been
organized around two polarized endpoints known as M1 or classical and M2 or alternative acti-
vation [31], recent evidence have revealed an unrecognized greater diversity in the ontogeny
and functional diversity of tissue-resident macrophages. It is now established that macrophages
from embryonic progenitors can persist in tissues into adulthood and self-maintain by local
proliferation (reviewed in [4, 5]). However, monocytes also contribute to the resident macro-
phage population, on which the local environment can impose tissue-specific macrophage
functions (reviewed in [4, 5]). The myeloid colony-stimulating factors, M-CSF and GM-CSF
are known to modulate macrophage phenotype and many studies illustrate their importance in
the magnitude, duration and character of inflammatory responses [32, 33]. Thus, the descrip-
tion of the distinct molecular phenotypes consequence of M-CSF or GM-CSF stimulation may
be important for both acute and chronic inflammatory pathology. Here, we show that differen-
tiation stimuli determine distinct cell proliferation and cell cycle progression in primary mac-
rophages, characteristics that are mostly dependent on the differential expression patterns of
cell cycle proteins, especially D-type cyclins, their catalytic partners, CDKs, and the CDK
inhibitor p21. Consistent with our observations, upregulation of cyclin D2 in response to
GM-CSF treatment has already been reported in different hematopoietic cells [34–36], suggest-
ing that cyclin D2 role might be relevant also for other cell types.
Fig 4. Cyclin D2 expression restricts HIV-1 replication by controlling SAMHD1 activation in GM-CSFmacrophages. (A) Effective and
specific knockdown of CCND2, CCND3, CDKN1A andCDK4 expression by siRNA in GM-CSFmacrophages. mRNA of the corresponding gene
was measured by quantitative PCR and normalized to GAPDH expression. Data represents mean ± SD of at least 3 different donors and is
normalized to Mock-transfected macrophages. (B) Protein expression and SAMHD1 activation in siRNA-treated GM-CSFmacrophages. Western
blot showing cyclin D2, cyclin D3, CDK4 and p21 protein expression and SAMHD1 expression and activation in siRNA-treated GM-CSF
macrophages. SAMHD1 inactivation by phosphorylation is increased in cyclin D2 and p21 knockdownmacrophages, compared to Mock-
transfected or macrophages treated with a non-targeting siRNA (siNT). (C) Evaluation of cell proliferation and cell cycle analysis in siRNA-treated
GM-CSFmacrophages. Histograms showing Ki67 staining (upper panels) and dot plots representing cell cycle profile by DNA (7-AAD) and RNA
(Pyronin Y) staining (lower panels) in siRNA-treated macrophages. Percentage of positive cells in a representative donor is shown in each case.
(D) HIV-1 replication in siRNA-treated GM-CSFmacrophages. Transfected MDMwere infected with a VSV-pseudotyped, GFP-expressing HIV-1
and infection measured 72h later by flow cytometry. Data represent percentage replication relative to mock-transfected macrophages. Mean ± SD
of at least 3 different donors performed in duplicate is shown. (E) Proviral DNA formation after 16h infection with HIV-1 BaL of GM-CSF
macrophages transfected with the indicated siRNA or treated with AZT (3 μM) or raltegravir (RAL; 2 μM). Proviral DNA was normalized to mock-
treated macrophages. Mean ± SD of at least 3 different donors is shown. * p<0.05; ** p<0.005; *** p<0.0005.
doi:10.1371/journal.ppat.1005829.g004
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Fig 5. Co-immunoprecipitation (IP) of cyclin D2 with p21. (A) Co-IP assay of 293T cells transfected with a plasmid expressing Flag-tagged
p21. Lysates frommock- transfected (M) HEK293T cells or transfected with a Flag-p21 expression plasmid (p21) were subjected to
immunoprecipitation with anti-Flag antibodies attached to sepharose or sepharose alone (B; beads). Whole cell lysates (WCL) and
immunoprecipitates were analyzed by immunoblotting with an anti-cyclin D2 antibody or different CDK antibodies (CDK4, CDK6 and CDK1).
Anti-p21 and anti-Hsp90 antibodies were used as controls. (B) Co-IP assay of 293T cells transfected with a plasmid expressing HA-tagged
cyclin D2. As in (A) Lysates frommock- transfected (M) HEK293T cells or transfected with a HA-cyclin D2 expression plasmid (D2) were
subjected to immunoprecipitation with anti-HA antibodies attached to sepharose or sepharose alone (B; beads). Whole cell lysates (WCL) and
immunoprecipitates were analyzed by immunoblotting with anti-p21, anti-CDK4 and anti-CDK1 antibodies. Anti-cyclin D2 and anti-Hsp90
antibodies were used as controls. (C) Co-IP assay of endogenous cyclin D2 and p21 in GM-CSF primary macrophages. Lysates from primary
macrophages where subjected to immunoprecipitation with anti-cyclin D2 or anti-p21 antibodies, attached to sepharose or sepharose attached
to IgG alone (B, beads). Whole cell lysate (WCL) and immunoprecipitates were analyzed by immunoblotting with anti-cyclin D2, anti-p21, anti-
CDK4 and anti-CDK1 antibodies. Anti-Hsp90 antibody was used as a control. For all Co-IP assays, a representative experiment out of 3 is
shown. (D) Quantification of endogenous immunoprecipitated proteins with anti-cyclin D2 (white bars) or anti-p21 antibodies (black bars). Mean
band density values ± SD of three independent donors is shown.
doi:10.1371/journal.ppat.1005829.g005
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The molecular interplay between the cell cycle, cyclins, and cell function is far from being
fully understood. Conceptual advances in the field continue to uncover novel and interesting
roles for cyclins in cellular processes that contribute to diseases, such as cancer or pathogenic
infections [37]. It is well accepted that cell cycle control plays a major role in determining sus-
ceptibility to HIV-1 infection [38, 39]. It has been previously shown that limiting dNTP syn-
thesis, for example through ribonucleotide reductase inhibition by hydroxyurea, limits HIV-1
replication [40]. Thus, differences on cell cycle regulation between M-CSF and GM-CSF mac-
rophages also determined the susceptibility to HIV-1 infection and this may be a direct conse-
quence of the control of the restriction factor SAMHD1 by CDK-mediated phosphorylation.
Previous observations in M-CSF macrophages, showed that SAMHD1 phosphorylation was
directly phosphorylated by CDK2, whose kinase activity was upstream regulated by the cyclin
D3-CDK6 complex [11, 16]. However, the molecular mechanism might be different in
GM-CSF macrophages because CDK6 was barely expressed and D-type cyclins expression was
Fig 6. Cyclin D2 expression controls subsequent activation of CDK1 and CDK2. (A) CDK1 and CDK2 gene expression in CCND2 and
CDKN1A knockdown GM-CSFmacrophages. CDK1 andCDK2 gene expression was measured by quantitative PCR and normalized to GAPDH
expression. Data represents mean ± SD of 3 different donors and is normalized to Mock-transfected macrophages. (B)Western blot showing CDK1
and CDK2 expression and phosphorylation of CDK2 in siRNA-treated GM-CSFmacrophages. CDK1 expression is upregulated after cyclin D2
knockdown as well as CDK2 activity measured as phosphorylation at Thr130, compared to Mock-transfected or macrophages treated with a non-
targeting siRNA (siNT). (C) Proposed regulatory model of Cyclin D2 mediated control of HIV-1 restriction in non-proliferating cells. The Cyclin D2/
CDK4/p21 complex is responsible for the lack of active CDK2 and CDK1 expression in GM-CSFmacrophages. This situation is reversed in the
absence of cyclin D2, leading to the activation of CDK2 and CDK1 with the subsequent phosphorylation of its substrates, including SAMHD1.
doi:10.1371/journal.ppat.1005829.g006
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significantly upregulated, especially that of cyclin D2. Accordingly, knockdown of cyclin D2
and cyclin D3 resulted in opposite effects depending on the macrophage type, in terms of sus-
ceptibility to HIV-1 infection: cyclin D2 restricts infection in non-cycling GM-CSF macro-
phages and cyclin D3 enables infection in proliferating M-CSF macrophages. All D-type
cyclins (D1, D2 and D3) are closely associated to the G1 phase, whose expression is induced by
mitogenic signals and therefore play a significant role in cell cycle entry, by assembling together
with CDK4 or CDK6 [18, 21, 37]. However, although apparently redundant, single knockout
mice exhibit several cell type specific abnormalities [21], suggestive of essential functions on
particular settings for each cyclin, explaining, in part, the apparently opposed effects observed
here for cyclin D2 and D3 when assessing susceptibility to HIV infection. On the other hand,
D-type cyclins are linked to many human malignancies. Cyclin D1 is a well-established onco-
gene (review in [18]) but cyclin D2 or cyclin D3 overexpression are rarely reported [41, 42].
However, CCND2 is frequently methylated, with loss of cyclin D2 expression in pancreatic,
breast and prostate cancer [43–45], pointing to a potential role as a tumor suppressor rather
than an oncogene, indicating that overexpression of cyclin D2 might be limiting cell prolifera-
tion, as described here in GM-CSF macrophages.
To uncover the molecular mechanism underlying cyclin D2 function in GM-CSF macro-
phages and taking into account that cyclins alone do not have catalytic activity per se, the study
of putative partners of cyclin D2 was addressed. In concordance with the differential gene
expression patterns, the inhibition of CDK4 which is similarly expressed in both macrophage
types did not change protein profile or HIV-1 susceptibility. Conversely, knockdown of the
CDK inhibitor p21, whose expression was also upregulated in GM-CSF macrophages, showed
the same effect as that of Cyclin D2, i.e., upregulation of SAMHD1 phosphorylation and
enhancement of HIV-1 replication, similar to our previous observation in M-CSF macrophages
[20]. p21 belongs to the Cip/Kip family of CDKIs that have historically been considered nega-
tive regulators of the cyclin-CDKs and therefore controlling cell cycle progression, especially
when referred to cyclin-CDK1 or -CDK2 complexes [20, 46]. However, Cip/Kip family of
CDKIs interaction with Cyclin D-CDK4/6 appear much more complex, being involved in both
the stabilization of the cyclin D/CDK complex but also acting as inhibitors of its kinase activity
[47, 48]. The observation that a complex formed by Cyclin D2/CDK4/p21 was identified in
non-cycling GM-CSF macrophages argues in favor of the inhibitory hypothesis at least in this
specific cell type. Moreover, the fact that p27, another Cip/Kip family member, is barely
expressed in GM-CSF macrophages indicates the specificity to the effect of Cyclin D2/CDK4/
p21 complex. A direct inhibition of CDK2 function, similar to that observed in M-CSF [20]
cannot be completely rule out, but seems improbable due to the low expression of CDK2 and
lack of cell proliferation markers seemed in GM-CSF macrophages.
The present works also highlights the interplay between cell cycle control and viral replica-
tion, with important implications that might be broader than simply affecting susceptibility to
HIV-1 infection. Interestingly, both p21 and Cyclin D2 were identified as potential markers for
viral latency, as both genes showed increased histone modification levels in HIV latently
infected cells [49]. These observation suggests that the maintenance or not of HIV-1 latency
may also be controlled by cell cycle related proteins such as Cyclin D2 and p21 and thus, open
the opportunity for new therapeutic interventions. In addition, p21 and Cyclin D2 were also
found upregulated after HTLV-I infection, a process that is mediated by the viral protein Tax,
indicating that deregulation of G1/S checkpoint is also relevant for other retroviruses [48].
In summary, the identification of a novel cell cycle-mediated viral restriction pathway in
primary non cycling macrophages have provided new evidences of the tight interplay between
viral replication and cell cycle control, pointing towards the concerted action of Cyclin D2 and
p21 in HIV-1 replication. The demonstration and characterization of specific D-type Cyclin
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roles in certain cell types, such as that reported for Cyclin D2 here, may also offer a window of
opportunity for targeting D Cyclins in viral infections and in human cancers as well, where D-
type Cyclin expression is frequently deregulated.
Materials and Methods
Cells
PBMC were obtained from buffy coats of blood of healthy donors using a Ficoll-Paque density
gradient centrifugation and monocytes were purified using negative selection antibody cock-
tails (StemCell Technologies) as described before [22]. Monocytes were cultured in complete
culture medium (RPMI 1640 medium supplemented with 10% heat-inactivated fetal bovine
serum (FBS; Gibco) or human serum (HS; Sigma) and penicillin/streptomycin (Gibco) and dif-
ferentiated to monocyte derived macrophages (MDM) for 4 days in the presence of monocyte-
colony stimulating factor (M-CSF, Peprotech) or granulocyte-macrophage colony-stimulating
factor (GM-CSF, Peprotech) both at 100 ng/ml. The protocol was approved by the scientific
committee of Fundació IrsiCaixa. Buffy coats were purchased from the Catalan Banc de Sang i
Teixits (http://www.bancsang.net/en/index.html). The buffy coats received were totally anony-
mous and untraceable and the only information given was whether or not they have been
tested for disease. When appropriate, differentiated macrophages were incubated with 100 ng/
ml of lipopolisaccaride (LPS, Sigma-Aldrich) overnight at 37°C.
TZM cells were received from the National Institutes of Health, AIDS Research and Refer-
ence Reagent Program. HEK293T cells were purchased from Dharmacon (Madrid, Spain).
Mice
Wild-type C57BL/6 inbred mice were purchased from Harlan Laboratories (Sant Feliu de
Codines, Barcelona, Spain) and housed at the Animal House facility at the Research Institute
Germans Trias i Pujol. Mice were housed under specific pathogen free conditions in a tempera-
ture and humidity-controlled room with 12-h light/12-h dark cycle. Only adult males were
used in this study. In vivo experiments were performed in strict accordance with the recom-
mendations in the Guide for the Care and Use of Laboratory Animals of the Generalitat de
Catalunya, Catalan Government and the Principles of laboratory animal care (NIH pub.85–23
revised 1985; http://grants1.nih.gov/grants/olaw/references/phspol.htm). Murine peritoneal
macrophages were isolated as described [50]. Briefly, C57Bl/6 mice were sacrificed by cervical
dislocation. Immediately after, peritoneal wall was exposed and 10 ml of a cold solution of PBS
with 3% FBS per mouse was injected into the peritoneal cavity. Using the same syringe and
needle, the fluid from the peritoneum was aspirated, and 8 ml of fluid was recovered. Peritoneal
fluid was centrifuged at 4°C and cell pellet was resuspended to adjust cell concentration at 1–3
x 106 cells / ml. To obtain monolayers of peritoneal macrophages, total cells were plated at
2–3 × 106 total nucleated cells/ml in DMEM/F12-10 medium. Cells were allowed to adhere for
1–2 hr at 37°C. Non-adherent cells were removed by gently washing three times with warm
PBS. At this time, cells were greater than 90% macrophages and were processed.
RNA interference
Isolated monocytes were transfected as previously described [11, 16]. Briefly, 50 pmol of the
corresponding siRNA (siGENOME SMARTpool from Dharmacon, Thermo-Scientific, Wal-
tham, USA and ThermoFisher Scientific), were transfected using a Monocyte Amaxa Nucleo-
fection kit (Lonza, Basel, Switzerland) following manufacturer instructions. Monocytes were
left untreated overnight and then differentiated to macrophages as described above.
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Flow cytometry
For intracellular Ki67 staining, cells were fixed for 3 min with Fixation Buffer (Fix & Perm, Life
Technologies) before adding pre-cooled 50% methanol for 10 min at 4°C. Cells were then
washed in PBS with 5% FBS and incubated for 30 min with the Ki-67 FITC antibody diluted in
permeabilitzation buffer (1:10; clone B56, BD Biosciences). For cell cycle analysis, cell were sus-
pended in 0.03% saponin (Sigma-Aldrich) in PBS and then incubated in 20 mM 7-aminoacti-
nomycin D (7AAD; Sigma-Aldrich) for 30 min at room temperature in the dark, followed by 5
min at 4°C. Then, Pyronin Y (Sigma-Aldrich) was added at a final concentration of 1.5 μg/ml
and cells were further incubated at 4°C for 15 min. Flow cytometry was performed in a LSRII
flow cytometer (BD Biosciences). The data were analyzed using the FlowJo software (BD Bio-
sciences). To correct the overestimation of G2/M population by miss discrimination of cellular
doublets, FL2W versus FL2A of the 7AAD dye was plotted before gating for the distinct cell
cycle phases [51].
Drugs
3-Azido-3-deoxythymidine (zidovudine, AZT) was purchased from Sigma-Aldrich (Madrid,
Spain). nevirapine (NVP) and raltegravir (RAL) were obtained from the NIH AIDS Research
and Reference Reagent Program. PD-0332991 (palbociclib) was purchased from Selleckchem.
Quantitative RT-polymerase chain reaction (qRT-PCR)
For relative mRNA quantification, RNA was extracted using the NucleoSpin RNA II kit
(Magerey-Nagel), as recommended by the manufacturer, including the DNase I treatment
step. Reverse transcriptase was performed using the High Capacity cDNA Reverse Transcrip-
tion Kit (Life Technologies). mRNA relative levels of all genes were measured by two-step
quantitative RT-PCR and normalized to GAPDHmRNA expression using the DDCt method.
Primers and DNA probes were purchased from Life Technologies (TaqMan gene expression
assays).
Cytokine expression was evaluated by using the commercial TaqMan Human Cytokine
Network array (4414255, Life Technologies), which included primers and probes for 28 differ-
ent cytokine genes. mRNA relative levels of all cytokine genes were measured by two-step
quantitative RT-PCR and normalized to GAPDHmRNA expression using the DDCt method.
Intracellular dNTP content was determined using a polymerase-based method [52] as previ-
ously described [23].
Viruses and virus infections
Envelope-deficient HIV-1 NL4-3 clone encoding IRES-GFP (NL4-3-GFP) was pseudotyped
with VSV-G by cotransfection of HEK293T cells using polyethylenimine (Polysciences) as pre-
viously described [11, 23]. For the production of viral-like particles carrying Vpx (VLPVpx),
HEK293T cells were cotransfected with pSIV3+ and a VSV-G expressing plasmid. Three days
after transfection, supernatants were harvested, filtered and stored at -80°C. Viral stocks were
concentrated using Lenti-X concentrator (Clontech). Viruses were titrated by infection of TZM
cells followed by GFP quantification by flow cytometry. R5-tropic HIV-1 strain BaL was grown
in stimulated PBMC and specifically titrated for its use in assays of total viral DNA formation
in MDM.
M-CSF or GM-CSF differentiated MDM were infected with VSV-pseudotyped NL4-3-GFP
and antiviral drugs were added at the time of infection. When necessary, differentiated MDM
were pretreated with VLPVpx for 4h before infection or left with fresh media as a control. Viral
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replication was measured in all cases two days later by flow cytometry (LSRII, BD Biosciences).
Measurement of cell cytotoxicity was performed by flow cytometry, i.e., cells were gated as liv-
ing or dead, according to flow cytometry FSC and SSC parameters. BaL infections were stopped
at 16h to measure only early events of viral infection (reverse transcription). For quantification
of proviral DNA, a primer and probe set that is able to amplify both unintegrated and inte-
grated viral DNA was used as described before [11, 16]. DNA was extracted using a DNA
extraction kit (Qiagen) and proviral DNA quantifications were performed. Ct values for provi-
ral DNA were normalized using RNaseP as housekeeping gene by the ΔΔCt method. Infections
were normalized to an untreated control. To ensure that measured proviral DNA was the prod-
uct of infection and not result from DNA contamination of the viral stocks samples treated
with RT inhibitor AZT (1 μM) were run in parallel. raltegravir (2 μM) was used to ensure that
no post-RT steps were being quantified by the assay.
Western blot
Cells were rinsed in ice-cold phosphate-buffered saline (PBS) and extracts prepared in lysis
buffer (50 mM Tris HCl pH 7.5, 1 mM EDTA, 1 mM EGTA, 1 mMNa3VO4, 10 mMNa β-gly-
cerophosphate, 50 mM NaF, 5 mM Na Pyrophosphate, 270 mM sucrose and 1% Triton X-100)
supplemented with protease inhibitor (Roche) and 1 mM phenylmethylsulfonyl fluoride.
Lysates were subjected to SDS-PAGE and transferred to a PVDF membrane (ImmunolonP,
Thermo). The following antibodies were used for immunoblotting: anti-rabbit and anti-mouse
horseradish peroxidase-conjugated secondary antibodies (1:5000; Pierce); anti-human Hsp90
(1:1000; 610418, BD Biosciences), anti-SAMHD1 (1:1000; ab67820, Abcam), anti-CDK1
(9116) anti-CDK2 (2546), anti-phosphoCDK2 (Thr160; 2561), anti-CDK4 (D9G3E), anti-
CDK6 (3136), anti-cyclin A2 (BF683), anti-cyclin D2 (D52F9), anti-cyclin D3 (DCS22), anti-
p21 (2947) and anti-p27 (2552) all 1:1000 from Cell Signaling. Anti-phospho-SAMHD1
Thr592 was obtained by immunization of rabbit using a phosphorylated peptide as described
before [53].
Co-immunoprecipitation assays
HEK293T cells were transfected with Flag-tagged p21 (Addgene plasmid # 16240, gift from
Mien-Chie Hung) [29] or HA-tagged Cyclin D2 (Addgene plasmid # 8950, gift from Philip
Hinds) [30] expression vectors using lipofectamine 2000 (Invitrogen). 48 h later, cells were
chilled to 4°C and cell extracts prepared with lysis buffer as described above. Lysates were
cleared by centrifugation at 10500 rpm for 10 min and incubated with anti-FLAG (anti-Flag
M2 Affinity Gel, Sigma) or anti-HA (monoclonal anti-HA-agarose, Sigma) antibodies cova-
lently attached to agarose overnight at 4°C on a rocking platform. Beads were then collected by
centrifugation at 3000 rpm for 5 min at 4°C, extensively washed in lysis buffer and resuspended
in SDS gel loading buffer. The proteins were separated on a 10% SDS-polyacrylamide gel,
transferred to a PVDF membrane, and analyzed by immunoblotting with the corresponding
antibodies.
Co-immunoprecipitation of endogenously expressed proteins was performed using
GM-CSF differentiated macrophages. Cell extracts were prepared as above and lysates were
incubated with anti-Cyclin D2 antibody (D52F9, Cell Signaling), anti-p21 antibody (2947, Cell
Signalling) or rabbit IgG overnight at 4°C and further incubated with Fast flow Sepharose
(Sigma-Aldrich) for 1-2h. Beads were then collected by centrifugation at 3000 rpm for 5 min at
4°C, extensively washed in lysis buffer and resuspended in SDS gel loading buffer. The proteins
were separated on a 10% SDS-polyacrylamide gel, transferred to a PVDF membrane, and ana-
lyzed by immunoblotting with the corresponding antibodies.
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Statistical methods
Data were analyzed with the PRISM statistical package. If not stated otherwise, all data were
normally distributed and expressed as mean ± SD. p-values were calculated using an unpaired,
two-tailed, t-student test.
Supporting Information
S1 Fig. Phenotypic characterization of M-CSF and GM-CSF macrophages. (A) Summary of
cell surface antigens expression. Markers of macrophage differentiation, HIV-1 receptor and
coreceptors and cell activation and proliferation markers were evaluated by flow cytometry.
The table shows mean ± SD of at least 3 different donors. nd, not detected. (B) Intracellular
dNTP levels in M-CSF or GM-CSF differentiated MDM. Intracellular dNTPs were extracted
fromM-CSF (left) or GM-CSF (right) differentiated MDM and dNTP content was determined
using a polymerase-based method. dNTP content is highly variable between donors and there-
fore data is relativized to M-CSF differentiated MDM. Mean ± SD of 3 different donors is
shown.  p<0.05
(TIFF)
S2 Fig. GM-CSF macrophages cultured with human serum (HS) or fetal bovine serum
(FBS) show lower proliferation rates, higher expression of cyclin D2 and are less susceptible
to HIV-1 infection compared to M-CSF. (A) Evaluation of cell proliferation by Ki67 staining.
Histograms of a representative donor showing Ki67 staining in M-CSF and GM-CSF derived
macrophages either with HS or FBS. Percentage of positive cells is shown in each case. (B) Dot
plots representing cell cycle profile showing DNA (7-AAD) and RNA (Pyronin Y) content of
M-CSF and GM-CSF differentiated macrophages cultured with HS or FBS and quantified by
flow cytometry. Data from a representative donor is shown. (C) Gene expression of cell cycle-
related genes and SAMHD1 restriction pathway. mRNA levels of SAMHD1, CDK2, CDK4 and
CDK6, all D-type cyclins (D1, D2 and D3) and the CDK inhibitors p21 (CDKN1A) and p27
(CDKN1B) was quantified in M-CSF, human serum (white bars) and M-CSF, FBS (black bars),
GM-CSF, human serum (light grey bars) and GM-CSF, FBS (dark grey bars) differentiated
macrophages. Data is normalized to M-CSF, FBS relative expression. Mean ± SD of 3 indepen-
dent donors is shown.  p<0.005;  p<0.0005. (D)Western blot showing protein expression
of different cell cycle proteins, SAMHD1 expression and activation and Hsp90 as loading con-
trol. A representative donor is shown. M; M-CSF MDM, GM; GM-CSF MDM. (E)HIV-1 rep-
lication in M-CSF MDM and GM-CSF MDM cultured with human serum (white bars) or fetal
bovine serum (FBS) (black bars). Data represent percentage replication relative to M-CSF cul-
ture with FBS. Mean ± SD of 3 different donors performed in triplicate is shown.  p<0.005;
 p<0.0005
(TIFF)
S3 Fig. Mouse peritoneal macrophages resemble GM-CSF expression profile. (A) Compara-
tive gene expression of cell cycle-related genes and SAMHD1 in mouse peritoneal macrophages
and human M-CSF and GM-CSF macrophages. mRNA levels of CCND2, CCND3, CDK2,
CDK4, SAMHD1 and the CDK inhibitors p21 (CDKN1A) and p27 (CDKN1B) were quantified
by real time PCR. Relative expression of each gene vs. GAPDH is plotted. Horizontal bars rep-
resent mean values.  p<0.05;  p<0.005;  p<0.0005; ns, not significant. (B) Western blot
showing protein expression in peritoneal macrophages from 3 different mice. Mice protein
expression was compared to different protein concentrations of GM-CSF and M-CSF human
macrophages in order to evaluate the relative levels of expression for each sample.
(TIFF)
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S4 Fig. Cyclin D2 restricts HIV-1 replication and proviral DNA formation in GM-CSF
macrophages. (A) SAMHD1 expression levels after knockdown of CCND2 and CCND3
expression by siRNA. Relative mRNA expression of SAMHD1 in M-CSF (white bars) and
GM-CSF (black bars) macrophages. SAMHD1mRNA was measured by quantitative PCR and
normalized to GAPDH expression. Data represents mean ± SD of 3 different donors and is
normalized to Mock-transfected M-CSF macrophages. (B) Effective knockdown of CCND2
expression with two different siRNA sequences (siCCND2#1 and siCCND2#2). CCND2
mRNA was measured by quantitative PCR and normalized to GAPDH expression. Data repre-
sents mean ± SD of 3 different donors and is normalized to Mock-transfected macrophages.
(C)HIV-1 replication in siCCND2 GM-CSF macrophages. Transfected MDM were infected
with a VSV-pseudotyped, GFP-expressing HIV-1 and infection measured 72h later by flow
cytometry. Data represent percentage replication relative to mock-transfected macrophages.
Mean ± SD of 3 different donors performed in duplicate is shown. (D) Proviral DNA forma-
tion after 16h infection with HIV-1 BaL of GM-CSF macrophages transfected with the indi-
cated siCCND2 sequences or treated with AZT (3 μM) or raltegravir (RAL; 2 μM). Proviral
DNA was normalized to mock-treated macrophages. Mean ± SD of 3 different donors is
shown.  p<0.05;  p<0.005;  p<0.0005.
(TIFF)
S5 Fig. Knockdown of cyclin D2 does not affect macrophage function. (A) Cytokine expres-
sion in GM-CSF siRNA-treated macrophages. Cytokine mRNA expression was measured using
a TaqMan Human Cytokine Network array and expression of each gene was normalized to
GAPDH. Data is normalized to Mock-transfected macrophages. Mean ± SD of 2 different donors
performed in duplicate is shown. (B) Induction of cytokine gene expression following LPS (100
ng/ml) treatment in siCCND2 GM-CSF macrophages. mRNA expression of CCL-2 and IL-10
was measured by quantitative PCR and normalized to GAPDH expression. Data is normalized to
untreated Mock-transfected GM-CSF macrophages. A representative donor is shown.
(TIFF)
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